​
​

Arcutis Biotherapeutics (ARQT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Arcutis Biotherapeutics Revenue Highlights

Latest Revenue (Y)

$59.61M

Latest Revenue (Q)

$30.86M

Main Segment (Y)

Other Revenue

Arcutis Biotherapeutics Revenue by Period

Arcutis Biotherapeutics Revenue by Year

DateRevenueChange
2023-12-31-1517.09%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Arcutis Biotherapeutics generated $59.61M in revenue during NA 2023, up 1517.09% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Arcutis Biotherapeutics Revenue by Quarter

DateRevenueChange
2024-06-30--37.75%
2024-03-31-266.47%
2023-12-31--64.51%
2023-09-30-634.28%
2023-06-30-86.62%
2023-03-31--6.08%
2022-12-31-308.41%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Arcutis Biotherapeutics generated $30.86M in revenue during Q2 2024, up -37.75% compared to the previous quarter, and up 1109.60% compared to the same period a year ago.

Arcutis Biotherapeutics Revenue Breakdown

Arcutis Biotherapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
Other Revenue--
Product--

Arcutis Biotherapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Other Revenue (51.04%), and Product (48.96%).

Quarterly Revenue by Product

Product/ServiceDec 23Sep 23Dec 22Sep 22
Product----
Other Revenue----

Arcutis Biotherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Product (98.05%), and Other Revenue (1.95%).

Arcutis Biotherapeutics Revenue Breakdown by Country

Quarterly Revenue by Country

CountryDec 22Sep 22
Product--

Arcutis Biotherapeutics's latest quarterly revenue breakdown by geography, as of Dec 22: Product (100.00%).

Arcutis Biotherapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AMLXAmylyx Pharmaceuticals--
APLSApellis Pharmaceuticals--
CHRSCoherus BioSciences--
MIRMMirum Pharmaceuticals--
SPROSpero Therapeutics--
ARQTArcutis Biotherapeutics--
VECTVectivBio--
BOLTBolt Biotherapeutics--
DSGNDesign Therapeutics--
XFORX4 Pharmaceuticals--
GRCLGracell Bio--
DAWNDay One Biopharmaceuticals--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
ERASErasca--
NLTXNeurogene--
TERNTerns Pharmaceuticals--
GLUEMonte Rosa Therapeutics--

ARQT Revenue FAQ

What is Arcutis Biotherapeutics’s yearly revenue?

Arcutis Biotherapeutics's yearly revenue for 2023 was $59.61M, representing an increase of 1517.09% compared to 2022. The company's yearly revenue for 2022 was $3.69M, representing an increase of 100.00% compared to 2021. ARQT's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Arcutis Biotherapeutics’s quarterly revenue?

Arcutis Biotherapeutics's quarterly revenue for Q2 2024 was $30.86M, a -37.75% decrease from the previous quarter (Q1 2024), and a 494.57% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $49.57M, a 266.47% increase from the previous quarter (Q4 2023), and a 1682.42% increase year-over-year (Q1 2023). ARQT's quarterly revenue for Q4 2023 was $13.53M, a -64.51% decrease from the previous quarter (Q3 2023), and a 356.81% increase year-over-year (Q4 2022).

What is Arcutis Biotherapeutics’s revenue growth rate?

Arcutis Biotherapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.

What are Arcutis Biotherapeutics’s revenue streams?

Arcutis Biotherapeutics's revenue streams in c 23 are Other Revenue, and Product. Other Revenue generated $30.42M in revenue, accounting 51.04% of the company's total revenue Product generated $29.19M in revenue, accounting 48.96% of the company's total revenue, up 691.81% year-over-year.

What is Arcutis Biotherapeutics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Arcutis Biotherapeutics was Other Revenue. This segment made a revenue of $30.42M, representing 51.04% of the company's total revenue.